BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1998;40:1049-1059. [PMID: 9539559 DOI: 10.1016/s0360-3016(97)00900-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Qian D, Chen X, Shang X, Wang Y, Tang P, Han D, Jiang H, Chen C, Zhao G, Zhou D, Cao F, Er P, Zhang W, Li X, Zhang T, Zhang B, Guan Y, Wang J, Yuan Z, Yu Z, Wang P, Pang Q. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random. Radiother Oncol 2022:S0167-8140(22)04176-7. [PMID: 35764191 DOI: 10.1016/j.radonc.2022.06.015] [Reference Citation Analysis]
2 Suwa T, Ishida Y, Negoro Y, Kusumi F, Kadokawa Y, Aizawa R, Nakajima T, Okamoto Y, Okuno Y, Yamada K, Ogura M, Murakami M, Mizowaki T. Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma. Clin Transl Radiat Oncol 2021;30:88-94. [PMID: 34430719 DOI: 10.1016/j.ctro.2021.08.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Eze C, Schmidt-Hegemann NS, Sawicki LM, Walter F, Manapov F. Revisiting the role of dose escalation in esophageal cancer in the era of modern radiation delivery. J Thorac Dis 2020;12:1624-7. [PMID: 32395301 DOI: 10.21037/jtd.2020.02.38] [Reference Citation Analysis]
4 Fassan M, Cavallin F, Guzzardo V, Kotsafti A, Scarpa M, Cagol M, Chiarion-Sileni V, Maria Saadeh L, Alfieri R, Castagliuolo I, Rugge M, Castoro C, Scarpa M. PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus. Cancer Med 2019;8:6036-48. [PMID: 31429521 DOI: 10.1002/cam4.2359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
5 Lin CS, Liu CY, Cheng CT, Tsai YC, Chiou LW, Lee MY, Liu CC, Shih CH. Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy. J Thorac Dis 2017;9:3193-207. [PMID: 29221296 DOI: 10.21037/jtd.2017.08.108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Hofstetter WL. Salvage esophagectomy. J Thorac Dis 2014;6 Suppl 3:S341-9. [PMID: 24876940 DOI: 10.3978/j.issn.2072-1439.2014.03.29] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
7 Matono S, Fujita H, Tanaka T, Mori N, Nagano T, Nishimura K, Hino H, Shirouzu K, Eto H, Ogo E, Yanagawa T. Salvage lymphadenectomy without esophagectomy is an option for recurrent or residual lymph nodes after definitive chemoradiotherapy for esophageal cancer. Esophagus 2014;11:197-203. [DOI: 10.1007/s10388-014-0430-z] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Kapoor R, Bansal A, Kochhar R, Kumar P, Sharma SC. Effectiveness of Two High-dose-rate Intraluminal Brachytherapy Schedules for Symptom Palliation in Carcinoma Esophagus: A Tertiary Care Center Experience. Indian J Palliat Care 2012;18:34-9. [PMID: 22837609 DOI: 10.4103/0973-1075.97347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, Takakuwa H, Matsusue S. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol 2006;45:1120-5. [PMID: 17118849 DOI: 10.1080/02841860600609768] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
10 Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]